These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 567282)

  • 21. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic effect of chlorpromazine on rat paradoxical sleep: a study of dose-related mechanisms.
    Kafi S; Gaillard JM
    Eur J Pharmacol; 1978 Jun; 49(3):251-7. PubMed ID: 26579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of synthesis inhibition on the levels of brain catecholamines in barbital-dependent rats.
    Morgan WW; Huffman RD; Pfeil KA; Gonzales EG
    Psychopharmacology (Berl); 1978 Jan; 56(1):41-4. PubMed ID: 415325
    [No Abstract]   [Full Text] [Related]  

  • 24. Diurnal rhythms in noradrenaline turnover and motility after reserpine and 6-hydroxydopamine.
    Lemmer B; Wenda K
    Pharmacol Biochem Behav; 1979 Mar; 10(3):361-8. PubMed ID: 572061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Egbe PC
    Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain.
    Weidenfeld J; Kahbha K; Reches A; Shohami E
    J Neurochem; 1992 Feb; 58(2):694-9. PubMed ID: 1345941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of catecholaminergic and cholinergic mechanisms in the pulsatile release of LH in the long-term ovariectomized rat.
    Gnodde HP; Schuiling GA
    Neuroendocrinology; 1976; 20(3):212-23. PubMed ID: 8741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental light conditions alter gene expression of rat catecholamine biosynthetic enzymes and Neuropeptide Y: differential effect in superior cervical ganglia and adrenal gland.
    Gallara RV; Bellavia SL; Serova LL; Sabban EL
    Brain Res Mol Brain Res; 2004 May; 124(2):152-8. PubMed ID: 15135223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 35. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of cerebral noradrenaline and dopamine depletion on spontaneous and amphetamine-stimulated motor activity in rats].
    Romero Vecchione E; Saturno N; Campos HA
    Acta Cient Venez; 1989; 40(2):113-8. PubMed ID: 2640764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholaminergic involvement in the effects of amphetamine isomers on seizure susceptibility.
    Gerald MC; Gupta TK
    Eur J Pharmacol; 1977 Jan; 41(2):231-4. PubMed ID: 832677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of reserpine, tranylcypromine, haloperidol and FLA-63 on physostigmine--induced hyperactivity in rats.
    Wray SR; Egbe PC
    West Indian Med J; 1980 Mar; 29(1):60-6. PubMed ID: 7385820
    [No Abstract]   [Full Text] [Related]  

  • 39. Automatic registration of behaviour related to dopamine and noradrenaline transmission.
    Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1976 Mar; 36(1):181-8. PubMed ID: 177298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pentylenetetrazol on carbaryl-induced changes in striatal catecholamines.
    Ray SK; Poddar MK
    Biochem Pharmacol; 1985 Feb; 34(4):553-7. PubMed ID: 3918540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.